Caredx Inc (CDNA)

2026-09-11T16:30:13.000Z - 2 days ago

CareDx management to meet with BTIG

2026-09-02T09:55:24.000Z - 11 days ago

CareDx initiated with a Buy at Canaccord

Aug 7, 2026, 4:01 PM EDT - 5 weeks ago

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-08-06T11:40:39.000Z - 5 weeks ago

CareDx price target raised to $60 from $45 at BTIG

2026-08-03T11:15:19.000Z - 5 weeks ago

Craig-Hallum ups CareDx to Buy, says guidance feels conservative

2026-08-03T11:10:16.000Z - 5 weeks ago

CareDx upgraded to Buy from Hold at Craig-Hallum

Jul 30, 2026, 4:30 PM EDT - 6 weeks ago

CareDx Earnings Call Transcript: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 6 weeks ago

CareDx Earnings release: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 6 weeks ago

CareDx Quarterly report: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 6 weeks ago

CareDx Slides: Q2 2026

2026-07-30T20:12:37.000Z - 6 weeks ago

CareDx raises FY26 revenue view to $490M-$500M, consensus $455.9M

2026-07-30T20:05:23.000Z - 6 weeks ago

CareDx reports Q2 EPS 37c, consensus 23c

Jul 30, 2026, 4:01 PM EDT - 6 weeks ago

CareDx Announces Second Quarter 2026 Financial Results

2026-07-16T17:20:27.000Z - 1 month ago

CareDx price target raised to $45 from $28 at BTIG

2026-07-16T14:10:11.000Z - 1 month ago

Craig-Hallum ups CareDx price target after ‘quite favorable’ Medicare LCD

2026-07-16T12:40:12.000Z - 1 month ago

CareDx announces finalization of Medicare Local Coverage Determination process

Jul 16, 2026, 8:35 AM EDT - 1 month ago

CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026

Jul 16, 2026, 8:30 AM EDT - 1 month ago

CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination

Jul 1, 2026, 4:05 PM EDT - 2 months ago

CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology

Jun 30, 2026, 4:05 PM EDT - 2 months ago

CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific

2026-06-18T11:19:56.000Z - 2 months ago

CareDx showcases precision medicine diagnostics at ATC 2026

Jun 18, 2026, 7:05 AM EDT - 2 months ago

CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress

2026-06-16T20:12:33.000Z - 2 months ago

CareDx announces second KOAR analysis published in JASN

Jun 16, 2026, 4:05 PM EDT - 2 months ago

CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology

Jun 11, 2026, 1:00 PM EDT - 3 months ago

CareDx Transcript: AGM 2026

Jun 8, 2026, 1:20 PM EDT - 3 months ago

CareDx Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 5, 2026, 8:00 AM EDT - 3 months ago

CareDx Proxy statement: Proxy filing

Jun 3, 2026, 5:30 PM EDT - 3 months ago

CareDx Transcript: Jefferies Global Healthcare Conference 2026

2026-06-01T16:20:10.000Z - 3 months ago

CareDx denied request to Supreme Court to revive Natera award

NTRA

May 20, 2026, 4:01 PM EDT - 3 months ago

CareDx to Participate in Upcoming Investor Conferences

2026-05-11T21:20:05.000Z - 4 months ago

CareDx announces dismissal of 2021 Qui Tam Suit

May 11, 2026, 4:05 PM EDT - 4 months ago

CareDx Announces Dismissal of 2021 Qui Tam Suit

2026-04-29T12:58:15.000Z - 4 months ago

CareDx price target raised to $28 from $26 at BTIG

2026-04-28T21:55:37.000Z - 4 months ago

CareDx files automatic mixed securities shelf

2026-04-28T21:42:11.000Z - 4 months ago

CareDx to acquire Naveris for $160M up-front, $100M in revenue milestones

2026-04-28T21:39:50.000Z - 4 months ago

CareDx raises FY26 revenue view to $447M-$465M from $420M-$444M

Apr 28, 2026, 4:30 PM EDT - 4 months ago

CareDx Earnings Call Transcript: Q1 2026

Apr 28, 2026, 4:30 PM EDT - 4 months ago

CareDx Earnings release: Q1 2026

Apr 28, 2026, 4:30 PM EDT - 4 months ago

CareDx Quarterly report: Q1 2026

Apr 28, 2026, 4:30 PM EDT - 4 months ago

CareDx Slides: Q1 2026

2026-04-28T20:16:32.000Z - 4 months ago

CareDx reports Q1 EPS 34c, consensus 13c

Apr 28, 2026, 4:05 PM EDT - 4 months ago

CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing

Apr 28, 2026, 4:01 PM EDT - 4 months ago

CareDx Announces First Quarter 2026 Financial Results

Apr 27, 2026, 8:00 AM EDT - 4 months ago

CareDx Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

CareDx Proxy statement: Proxy filing

Apr 21, 2026, 4:01 PM EDT - 4 months ago

CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation's 46th Annual Meeting

Apr 20, 2026, 7:05 AM EDT - 4 months ago

CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing

Apr 16, 2026, 2:00 AM EDT - 5 months ago

Eurobio scientific signs definitive agreement to acquire CareDx's transplant Lab Product division

Apr 15, 2026, 4:30 PM EDT - 5 months ago

CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results

Apr 14, 2026, 4:01 PM EDT - 5 months ago

CareDx to Report First Quarter 2026 Financial Results on April 28, 2026

Mar 5, 2026, 4:01 PM EST - 6 months ago

CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets

Mar 3, 2026, 10:25 AM EST - 6 months ago

CareDx Transcript: 47th Annual Raymond James Institutional Investor Conference

Feb 24, 2026, 5:15 PM EST - 6 months ago

CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer

Feb 24, 2026, 4:30 PM EST - 6 months ago

CareDx Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

CareDx Annual report: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

CareDx Earnings release: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

CareDx Slides: Q4 2025

Feb 24, 2026, 4:01 PM EST - 6 months ago

CareDx Announces Fourth Quarter and Full Year 2025 Financial Results

Feb 18, 2026, 8:00 AM EST - 6 months ago

CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference

Feb 12, 2026, 10:00 AM EST - 7 months ago

CareDx Transcript: Status update

Feb 12, 2026, 10:00 AM EST - 7 months ago

CareDx Press release: Status update

Feb 12, 2026, 10:00 AM EST - 7 months ago

CareDx Slides: Status update

Feb 12, 2026, 7:05 AM EST - 7 months ago

CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy

Feb 10, 2026, 4:01 PM EST - 7 months ago

CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Feb 3, 2026, 7:05 AM EST - 7 months ago

CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings

Jan 27, 2026, 4:05 PM EST - 7 months ago

CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 12, 2026, 7:05 AM EST - 8 months ago

CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

Jan 7, 2026, 7:05 AM EST - 8 months ago

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

TXG

Dec 18, 2025, 5:00 PM EST - 8 months ago

CareDx Provides Notice of Proposed Derivative Settlement

Dec 3, 2025, 4:30 PM EST - 9 months ago

CareDx Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 24, 2025, 4:05 PM EST - 9 months ago

SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation

Nov 20, 2025, 9:00 AM EST - 9 months ago

CareDx Transcript: Stephens Annual Investment Conference

Nov 6, 2025, 8:00 AM EST - 10 months ago

CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

CareDx Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

CareDx Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

CareDx Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

CareDx Slides: Q3 2025

Nov 4, 2025, 4:05 PM EST - 10 months ago

CareDx Announces Third Quarter 2025 Financial Results

Oct 27, 2025, 7:05 AM EDT - 10 months ago

CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer

Oct 23, 2025, 4:05 PM EDT - 10 months ago

CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure

Oct 22, 2025, 4:01 PM EDT - 10 months ago

CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors

Oct 21, 2025, 8:00 AM EDT - 10 months ago

CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025

Oct 6, 2025, 7:05 AM EDT - 11 months ago

CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting

Sep 5, 2025, 8:00 AM EDT - 1 year ago

CareDx Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 2, 2025, 4:01 PM EDT - 1 year ago

CareDx Issues Comment Letter on Draft LCD Policy

Aug 21, 2025, 4:01 PM EDT - 1 year ago

CareDx to Participate in Wells Fargo Healthcare Conference

Aug 6, 2025, 4:57 PM EDT - 1 year ago

CareDx Announces Appointment of Nathan Smith as Chief Financial Officer

Aug 6, 2025, 4:30 PM EDT - 1 year ago

CareDx Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

CareDx Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

CareDx Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

CareDx Slides: Q2 2025

Aug 6, 2025, 4:01 PM EDT - 1 year ago

CareDx Announces Second Quarter 2025 Financial Results

Aug 6, 2025, 12:56 PM EDT - 1 year ago

CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation

Jul 31, 2025, 4:01 PM EDT - 1 year ago

CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress

Jul 23, 2025, 7:05 AM EDT - 1 year ago

CareDx to Report Second Quarter 2025 Financial Results

Jul 18, 2025, 8:00 AM EDT - 1 year ago

CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection

Jun 9, 2025, 3:20 PM EDT - 1 year ago

CareDx Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 5, 2025, 10:30 AM EDT - 1 year ago

CareDx Transcript: Jefferies Global Healthcare Conference 2025

Jun 5, 2025, 10:30 AM EDT - 1 year ago

CareDx Slides: FY 2025

Jun 3, 2025, 4:30 PM EDT - 1 year ago

CareDx Announces Repurchase of 5% of Outstanding Shares

Apr 30, 2025, 4:30 PM EDT - 1 year ago

CareDx Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

CareDx Quarterly report: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

CareDx Earnings release: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

CareDx Slides: Q1 2025

Apr 30, 2025, 4:05 PM EDT - 1 year ago

CareDx Reports First Quarter 2025 Results

Apr 29, 2025, 7:05 AM EDT - 1 year ago

CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting

Apr 28, 2025, 8:00 AM EDT - 1 year ago

CareDx Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

CareDx Proxy statement: Proxy Filing

Apr 24, 2025, 7:05 AM EDT - 1 year ago

CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting

Apr 21, 2025, 4:01 PM EDT - 1 year ago

CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Apr 8, 2025, 7:05 AM EDT - 1 year ago

CareDx to Report First Quarter 2025 Financial Results